A competition for undergraduate students to foster the design and development of innovative diagnostic and therapeutic devices, and technologies to aid underserved populations and the disabled is being sponsored by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health.
Press Releases · November 16, 2011
Science Highlights · November 7, 2011
To reduce failure of vascular interventions, researchers devised a new technology that may one day be used to deliver gene therapy to selected cells in the blood vessel wall. Therapeutic genes and other agents are packaged into nanoscale polymer films that can be coated onto surgical devices for localized therapy.
NIBIB in the News · October 24, 2011
Connecticut’s efforts to become a bioscience leader are discussed at the time of the annual conference of the Biomedical Engineering Society conference in Hartford. Dr. Pettigrew indicated the need for technological innovation. He pointed to NIBIB-funded efforts at Yale and the University of Connecticut. Read the full article from Hartford Business.
Press Releases · October 13, 2011
Roderic Pettigrew, Ph.D., M.D., Director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health has been selected to receive the 2011 Distinguished Achievement Award from the Biomedical Engineering Society (BMES).
NIBIB in the News · October 5, 2011
The tiniest structures in cells can be seen only using sophisticated instrumentation and informatics, but what biologists really need are improved fluorescent probes. Although advances in instrumentation and informatics should not be overlooked, many researchers believe that it is better-performing fluorescent labels that will allow super-resolution microscopy to continue to move forward. George Patterson, NIBIB Intramural Program, comments on fluorescent proteins. Read the full article from Nature.
NIBIB in the News · September 26, 2011
This article examines the role of nanoparticles in personalized medicine and how they are used for both therapeutics and diagnostics. In regard to the successful use of nanomaterials in personalized medicine, Dr. Xiaoyuan (Shawn) Chen, NIBIB, highlighted the importance of imaging methods to follow the release and efficacy of a drug. Read the full article from Chemical & Engineering News.
Science Highlights · July 29, 2011
One day in the near future, doctors may have an all-in-one device for quick and reliable identification of patients infected with dangerous microbe strains. This lab-on-a-chip will be able to detect even the smallest amounts of infectious particles in biological samples, food, and water.
Science Highlights · June 29, 2011
Magnetic resonance imaging (MRI) is a powerful tool for breast cancer detection. To extend MRI’s diagnostic capabilities, Stanford University researchers have developed a new coil array and image-processing technique that creates sharper MRI scans to reveal the fine structures of the breast and key features of breast lesions not currently visible.
Grantee News · June 28, 2011
Based on recent analysis of the personalized medicine market, Frost & Sullivan recognizes NIBIB grantee QuantaLife, Inc. with the 2011 North America Frost & Sullivan Award for New Product Innovation for its Droplet Digital Polymerase Chain Reaction (ddPCR) System. The QuantaLife ddPCR System introduces the next generation of PCR by providing absolute quantification of nucleic acid molecules. Read the full article from PR Newswire.